HK inno.N
VC Fund
Seoul, South Korea
HK inno.N is a VC fund in Seoul focused on Health Care and Biotechnology. CJ HealthCare Corp. develops pharmaceutical vaccines.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries HK inno.N invests in
Stages HK inno.N invests in
Countries HK inno.N invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Manufacturing 2 (40%)
- Pharmaceutical 2 (40%)
- Medical 1 (20%)
Stage
- Seed 1 (20%)
- Series A 1 (20%)
- Series B 1 (20%)
- Corporate Round 1 (20%)
- Venture - Series Unknown 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Seokhee Kang
CEO
|
CEO | Total investments: 0 | Find email | |
Yoonhee Kim
Senior Analyst, Business Development
|
Senior Analyst, Business Development | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Protium Science is a drug research and development company that provides analytical and quality assurance services. | $1.5M / Corporate Round / Apr 04, 2024 | ||
| Oncobix is an operator of a drug development company that develops innovative treatments for rare and incurable diseases that are challenging to treat with modern medicine. For the well-being of humanity, the company invented a novel compound that can be represented by a chemical formula or a salt thereof, along with a pharmaceutical compositioncontaining the compound, so that patients can enjoy innovative new drugs. | $2.8M / Series B / Sep 23, 2022 | ||
| Y-Biologics is specialized in antibody drug since its inception has focused on research and development. They have successfully constructed the unique human antibody library Y-max ABL and new dual antibody platform technology ALiCE. Based on this, they have developed various antibody drugs and become a leading company in the globalimmuno-chemotherapeutic drug market They are doing their best to leap forward. | $24.9M / Venture - Series Unknown / Feb 24, 2022 | ||
| AIO Foods is a food-tech startup that designs and manufactures personalized food. | Seed / Aug 27, 2021 | ||
| Next&Bio is a company that provides researchers and consumers with a new concept of medicine and pharmacy based on original technology. | $5.3M / Series A / Apr 03, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does HK inno.N invest in?
HK inno.N invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact HK inno.N?
Public channels for HK inno.N include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HK inno.N?
The team at HK inno.N includes Seokhee Kang (CEO) and Yoonhee Kim (Senior Analyst, Business Development). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
